The levonorgestrel-releasing intrauterine system provides a reliable, long-term treatment option for women with idiopathic menorrhagia

Archives of Gynecology and Obstetrics

Volumn 285, Issue 1, 2012, Pages 117-121

  Endrikat, Jan ^a,b   Vilos, George ^c   Muysers, Christoph ^a   Fortier, Michel ^d   Solomayer, Erich ^b   Lukkari Lax, Eeva ^e  

^a BAYER PHARMA AG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d Clinique de Recherche en Sante des Femmes   (Canada)

^e Bayer HealthCare Oy   (Finland)

Author keywords

Idiopathic menorrhagia; Levonorgestrel releasing intrauterine system

Indexed keywords

FERRITIN; HEMOGLOBIN; LEVONORGESTREL;

ADULT; ALKALINE HEMATIN METHOD; ANALYTIC METHOD; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN ANALYSIS; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC MENORRHAGIA; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; LONG TERM CARE; MAJOR CLINICAL STUDY; MENORRHAGIA; MULTICENTER STUDY; PICTORIAL BLOOD LOSS ASSESSMENT CHART; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; BLOOD; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUATION; META ANALYSIS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ADULT; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MENORRHAGIA; MENSTRUATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84860798206     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1902-1     Document Type: Article

References (30)

1. Speroff L, Fritz M (2004) Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott Williams & Wilkins, Baltimore, pp 575-593
2. OK Reid P, Virtanen-Kari S (2005) Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 112(8):1121-1125
3. Milsom I, Andersson K, Andersch B, Rybo G (1991) A comparison of flurbiprofen, tranexamic acid, and a levonorgestrelreleasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 164:879-883
4. Kari S (2005) Randomized, open-label, multicenter study comparing the efficacy and safety of Mirena to a 3-month administration of danazol followed by a 3-month observation period in women aged over 30 with functional menorrhagia: Berlex Canada; Report No.: A00696/DE00650-303003. Data on file
5. Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M (2009) A Canadian, multicentre study comparing the efficacy of a levonorgestrel- releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. JOGC 31:340-347
6. OK Lahteenmaki P, Haukamaa M, Puolakka J, Riikonen U, Sainio S, Suvisaari J et al (1998) Open randomized study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ 316:1122-1126
7. OK Nagrani R, Bowen-Simpkins P, Barrington JW (2002) Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia? BJOG 109:345-347
8. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivela A et al (2004) Clinical outcomes and costs with the levonorgestrel- releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 291:1456-1463
9. Inki P (2007) Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 75(Suppl 6):S161-S166
10. OK Mansour D (2007) Modern management of abnormal uterine bleeding - the levonorgestrel intra-uterine system. Best Pract Res Clin Obstet Gynaecol 21:1007-1021
11. Tang GWK, Lo SST (1995) Levonorgestrel intrauterine device in the treatment of menorrhagia in chinese women: efficacy versus acceptability. Contraception 51(4):231-235
12. OK Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT (1998) Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 105:592-598
13. Scholten PC, Christiaens GCML, Haspels AA (1989) Treatment of menorrhagia by intrauterine administration of levonorgestrel. The levonorgestrel IUD: clinical performance and impact on menstruation. University of Utrecht, Utrecht, pp 47-55
14. OK Luukkainen T, Toivonen J (1995) Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 52:269-276
15. OK Rauramo I, Elo I, Istre O (2004) Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 104(6):1314-1321
16. OK Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O (1997) Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 90:257-263
17. OK Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos S (2009) Levonorgestrel-realising intrauterine system and endometrial ablation in heavy menstrual bleeding. Obstet Gynecol 113:1104-1116
18. Muenzen R (2009) A multicenter, randomized, open label, parallel group, active control study to evaluate the efficacy and safety of LNG IUS (Mirena) as compared to medroxyprogesterone acetate during 6 cycles of treatment in patients with idiopathic menorrhagia. BSP Report A38313, 23 Jan. Data on file
19. Higham J, O'Brien PMS, Shaw RW (1990) Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97:734-739
20. OK Hallberg L, Nilsson L (1964) Determination of menstrual blood loss. Scand J Clin Lab Invest 16:244-248
21. Janssen CA, Scholten PC, Heintz AP (1995) A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 85(6):977-982
22. OK Xiao B, Wu SC, Chong J, Zeng T, Han LH, Luukkainen T (2003) Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertil Steril 79(4):963-969
23. Kriplani A, Singh BM, Lal S, Agarwal N (2007) Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia. Int J Gynaecol Obstet 97:190-194
24. OK Barrington JW, Bowen-Simpkins P (1997) The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 104(5):614-616
25. OK Hurskainen R, Paavonen J (2004) Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding. Curr Opin Obstet Gynecol 16:487-489
26. Hurskainen R, Teperi J, Rissanen P, Aalto AM et al (2004) Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 291:1503-1504
27. National Collaborating Center for Women's, Children's Health (2007) Heavy menstrual bleeding. Clinical guideline. RCOG Press, London, pp 116-120
28. OK Chrisman C, Ribeiro P, Dalton VK (2007) The levonorgestrelreleasing intrauterine system: an updated review of the contraceptive and noncontraceptive uses. Clin Obst Gynecol 50:886-897
29. OK Andersson K, Batar I, Rybo G (1992) Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 46:575-584
30. OK Belhadj H, Sivin I, Diaz S et al (1986) Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 34:261-267